School Inner City Air Study

Status Not yet recruiting

Clinical Trial Summary

The goal of this randomized clinical trial is to test the efficacy of high efficiency particulate air (HEPA) cleaners in reducing respiratory viral exposure and infections in elementary school classrooms. Classrooms will be randomized to active vs. sham HEPA cleaners. The main questions it aims to answer are: - Do classroom HEPA cleaners reduce exposure to viruses? - Do classroom HEPA cleaners reduce student and teacher infections? - Do classroom HEPA cleaners reduce infections in family members?

Clinical Trial Description

Classrooms from participating schools will be randomized to active vs. sham HEPA cleaners. From enrolled classrooms, we will enroll students, teachers, and members of the household. We will collect the following: - longitudinal classroom air samples - longitudinal upper respiratory samples - longitudinal symptom surveys using the Wisconsin Upper Respiratory Symptom Survey (WURSS) Viral testing on collected air and respiratory samples will be performed using digital polymerase chain reaction (dPCR). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05953233
Study type	Interventional
Source	Massachusetts General Hospital
Contact	Peggy Lai, MD MPH
Phone	617-875-9878
Email	plai@mgh.harvard.edu
Status	Not yet recruiting
Phase	N/A
Start date	September 2023
Completion date	August 2030

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05568953` - An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity	Phase 2
Not yet recruiting	`NCT05902702` - Isotonic Saline for Children With Bronchiolitis	N/A
Completed	`NCT01570283` - ARMS - Rapidly Generated Multivirus-Specific CTLs for Prophylaxis & Treatment of EBV, CMV, Adenovirus, HHV6 & BK Virus	Phase 1/Phase 2
Not yet recruiting	`NCT01159470` - The Rate of C-reactive Protein (CRP) Increase as a Marker for Bacterial Infections in Children	N/A
Recruiting	`NCT02532452` - Third Party Viral Specific T-cells (VSTs)	Phase 2
Recruiting	`NCT05246098` - REVIVe: Frailty, Rehabilitation, and Outcomes in Critically Ill Adult and Pediatric Survivors of COVID-19 or ARI
Recruiting	`NCT05603650` - Effects of Mouthrinses on the Microbiome of the Oral Cavity and GI Tract	N/A
Completed	`NCT04525456` - Immune Responses With Reduxium	N/A
Completed	`NCT04643678` - Anakinra in the Management of COVID-19 Infection	Phase 2/Phase 3
Completed	`NCT03189537` - Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections	Phase 3
Completed	`NCT04267809` - Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection	Phase 2
Completed	`NCT00341081` - Validation of Self-Reported Needle Sharing Among Injection Drug Users	N/A
Recruiting	`NCT04088916` - Proviral DNA as a Target for HIV-1 Resistance Analysis
Terminated	`NCT04401410` - Anti-SARS Cov-2 T Cell Infusions for COVID 19	Phase 1
Terminated	`NCT00952185` - Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers	N/A
Recruiting	`NCT06149494` - RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection	Phase 2
Active, not recruiting	`NCT04254991` - A Controlled, Blinded Study to Validate the Diagnostic Accuracy and Assess the Clinical Utility of a Host-response Based Diagnostic Tool for Distinguishing Between Bacterial and Viral Etiologies in Pediatric Patients Presenting to the ED With Suspicion of Acute Infection
Completed	`NCT05897801` - Distinguishing Bacterial and Viral Infections by MeMed BV® Test to Limit Gut Colonization by MDRO
Terminated	`NCT02696291` - Safety and Pharmacokinetics of UV-4B Solution Administered Orally as Multiple Ascending Doses to Healthy Subjects	Phase 1
Recruiting	`NCT02456610` - Administration of Virus Specific CTLs for the Prophylaxis and Treatment of EBV/CMV Infections After HSCT in China	Phase 1